Tyana T Joseph

Ms. Tyana T Joseph

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
TJTyana T Joseph
Tyana T Joseph
VSViviane Schuch
Viviane Schuch
DHDaniel J. Hossack
Daniel J. Hossack
RCRana Chakraborty
Rana Chakraborty
EJErica L. Johnson
Erica L. Johnson
Melatonin (N-acetyl-5-methoxytryptamine) is an indolamine hormone with many physiological and biological roles. Melatonin is an antioxidant, anti-inflammatory, free radical scavenger, circadian rhythm regulator, and sleep hormone. However, its most popular role is the ability to regulate sleep through the circadian rhythm. Interestingly, recent studies have shown that melatonin is an important and essential hormone during pregnancy, specifically in the placenta. This is primarily due to the placenta’s ability to synthesize its own melatonin rather than depending on the pineal gland. During pregnancy, melatonin acts as an antioxidant and anti-inflammatory, which is necessary to ensure a stable environment for both the mother and the fetus. It is an essential antioxidant in the placenta because it reduces oxidative stress by constantly scavenging for free radicals, i.e., maintain the placenta’s integrity. In a healthy pregnancy, the maternal immune system is constantly altered to accommodate the needs of the growing fetus, and melatonin acts as a key anti-inflammatory by regulating immune homeostasis during early and late gestation. This literature review aims to identify and summarize melatonin’s role as a powerful antioxidant and anti-inflammatory that reduces oxidative stress and inflammation to maintain a favorable homeostatic environment in the placenta throughout gestation.

10 September 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
ABAlaijah Bashi
Alaijah Bashi
VSViviane Schuch
Viviane Schuch
ADAmber Dawning
Amber Dawning
TJTyana T Joseph
Tyana T Joseph
PBPeter Baltrus
Peter Baltrus
EJErica L Johnson
Erica L Johnson
Background/Objectives: Food insecurity (FI) affects a substantial proportion of pregnant individuals in the United States and varies across geographic contexts. Rural and urban communities differ in food access, socioeconomic conditions, and environmental exposures, yet how these differences relate to maternal biology remain misunderstood. Methods: This study examined associations between FI, geographic context, and metabolic, nutritional, and inflammatory biomarkers among pregnant participants in the Southeastern United States (SE-US) using data from the All of Us (AoU) Research Program. Survey, clinical, and laboratory data were integrated with ZIP3-level geographic and food environment indicators. Analyses were conducted using biomarker-specific complete-case cohorts and multivariable regression models. Results: This study found that FI was more prevalent among rural participants than urban participants. However, in the overall cohort, FI was associated with higher body mass index, higher non-fasting glucose, higher C-reactive protein, and lower high-density lipoprotein cholesterol. Pregnant food-insecure participants also exhibited lower concentrations of vitamin B12, albumin, vitamin D, and folate, while ferritin did not differ. Stratified analyses demonstrated variability in these associations by urbanicity, with stronger and more consistent differences observed in urban populations and fewer significant differences in rural settings. Conclusions: Limitations of this study include potential residual confounding, EHR-related selection bias, exposure misclassification, and limited generalizability. Despite the limitations, recent self-reported household FI, assessed at enrollment and referring to the preceding 12 months, was associated with differences in several metabolic and nutritional biomarkers, with patterns varying by geographic context. Further longitudinal research is needed to clarify these associations and inform targeted interventions.

22 September 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
TJTyana T Joseph
Tyana T Joseph
TAToidi Adekambi
Toidi Adekambi
KBKyra Brewer
Kyra Brewer
VSViviane Schuch
Viviane Schuch
NTNia Thompson
Nia Thompson
EJErica L Johnson
Erica L Johnson
Melatonin regulates inflammation and oxidative stress at the placenta, but its effects on specific placental cell types remain unclear. This study investigated how melatonin influences inflammatory and oxidative stress responses, cytokine secretion, NRF2-associated antioxidant responses, and transcriptomic responses in JEG-3 trophoblast-like cells and primary decidual macrophages exposed to lipopolysaccharide (LPS). Melatonin reduced LPS-induced inflammatory cytokine production and intracellular reactive oxygen species accumulation, with pretreatment producing the strongest anti-inflammatory effects. Although NLRP3 transcript expression differed according to treatment sequence, melatonin was associated with reduced inflammatory cytokine secretion despite limited changes in total NLRP3 protein expression. Melatonin also differentially influenced antioxidant responses across placental cell types, with decidual macrophages exhibiting broader functional and transcriptional changes than JEG-3 trophoblast-like cells. Transcriptomic profiling revealed dose- and cell type-dependent effects, with decidual macrophages exhibiting altered expression of genes and pathways associated with inflammatory signaling, oxidative phosphorylation, and reactive oxygen species regulation. In contrast, JEG-3 trophoblast-like cells demonstrated limited transcriptional remodeling and more modest engagement of inflammatory signaling pathways than primary decidual macrophages. These findings suggest that melatonin differentially modulates inflammatory and oxidative stress responses across placental cell types at the maternal-fetal interface. Collectively, these data support the potential role of melatonin in promoting placental redox-inflammatory balance during inflammatory stress and provide a foundation for future studies in physiologically relevant models.

2 November 2026 in Epigenomes
Verified
Journal Article
Open access
PDF file
ADAmber Dawning
Amber Dawning
RORaimot A. Olanrewaju
Raimot A. Olanrewaju
MDMelissa Davis
Melissa Davis
JJJames W. Lillard Jr.
James W. Lillard Jr.
RMRobert Meller
Robert Meller
EJErica L Johnson
Erica L Johnson
Preterm birth (PTB) remains a leading cause of neonatal morbidity and mortality worldwide, with limited tools for early prediction or targeted prevention. Increasing evidence identifies the placenta as a central regulator of gestational duration, and alterations in placental gene regulatory programs have been associated with PTB. This review synthesizes recent advances in placental genomics and epigenomics, emphasizing how cell-type-specific regulatory landscapes shape PTB risk. We describe how DNA methylation, chromatin accessibility, and transcriptional heterogeneity across trophoblasts, Hofbauer cells, endothelial cells, Natural Killer (NK) cells, and mesenchymal stromal cells integrate maternal, fetal, immune, and environmental signals. We further evaluate emerging liquid biopsy approaches, focusing on circulating cell-free placental DNA (cfpDNA) methylation as a minimally invasive strategy to detect placental dysfunction. Single-cell and long-read sequencing technologies have enabled high-resolution mapping of placental regulatory architecture, revealing cell-type-specific pathways underlying inflammation, impaired trophoblast differentiation, and aberrant vascular remodeling. These studies support the investigation of placental epigenetic alterations as potential contributors to PTB-associated biology, although their causal roles and consistency across PTB subtypes remain uncertain. Circulating cfpDNA methylation profiles are being investigated as minimally invasive indicators of placental biology, but their accuracy and clinical utility for PTB prediction require further validation. Together, these findings suggest that epigenomic alterations may be associated with biological pathways implicated in PTB and may also provide measurable molecular signatures in maternal circulation.